Your browser is no longer supported. Please, upgrade your browser.
Settings
CPIX Cumberland Pharmaceuticals Inc. daily Stock Chart
CPIX [NASD]
Cumberland Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.44 Insider Own40.90% Shs Outstand15.47M Perf Week2.60%
Market Cap109.68M Forward P/E- EPS next Y- Insider Trans0.04% Shs Float9.36M Perf Month2.75%
Income-7.10M PEG- EPS next Q- Inst Own35.00% Short Float0.99% Perf Quarter2.46%
Sales36.20M P/S3.03 EPS this Y-236.00% Inst Trans-1.13% Short Ratio5.70 Perf Half Y10.78%
Book/sh4.16 P/B1.70 EPS next Y- ROA-7.80% Target Price5.50 Perf Year42.08%
Cash/sh3.17 P/C2.24 EPS next 5Y30.00% ROE-9.90% 52W Range4.60 - 7.49 Perf YTD28.91%
Dividend- P/FCF- EPS past 5Y-17.20% ROI-1.40% 52W High-5.34% Beta0.96
Dividend %- Quick Ratio4.40 Sales past 5Y-8.40% Gross Margin81.70% 52W Low54.13% ATR0.31
Employees82 Current Ratio4.90 Sales Q/Q17.60% Oper. Margin-8.70% RSI (14)56.66 Volatility4.65% 4.61%
OptionableYes Debt/Eq0.10 EPS Q/Q- Profit Margin-19.60% Rel Volume0.77 Prev Close6.98
ShortableYes LT Debt/Eq0.10 EarningsAug 08 AMC Payout- Avg Volume16.26K Price7.09
Recom3.00 SMA202.60% SMA503.12% SMA20011.04% Volume12,478 Change1.58%
Nov-12-12Reiterated UBS Neutral $6.50 → $5
Feb-01-11Reiterated UBS Neutral $8 → $6.50
Dec-16-10Downgrade UBS Buy → Neutral $10 → $8
Aug-17-10Reiterated UBS Buy $11 → $10
Aug-17-10Reiterated Morgan Joseph Buy $15 → $10
Aug-17-10Downgrade Jefferies Buy → Hold $13 → $5.50
May-14-10Reiterated Morgan Joseph Buy $21 → $15
Sep-13-17 06:07PM  What Are The Drivers Of Cumberland Pharmaceuticals Incs (CPIX) Risks? Simply Wall St.
Aug-17-17 06:11PM  Edited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 11:15PM  Cumberland reports 2Q loss Associated Press
04:05PM  Cumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter PR Newswire
11:10AM  Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 04:15PM  Cumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results PR Newswire
Jul-31-17 08:15AM  Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support PR Newswire
Jul-12-17 02:24PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017 Capital Cube
May-25-17 12:37PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : May 25, 2017 Capital Cube
May-24-17 10:13AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 Capital Cube
May-21-17 12:55PM  Edited Transcript of CPIX earnings conference call or presentation 15-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-15-17 05:26PM  Cumberland reports 1Q loss Associated Press
04:05PM  Cumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017 PR Newswire
02:30PM  Investor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call Accesswire
May-08-17 04:05PM  Cumberland Pharmaceuticals to Announce First Quarter 2017 Financial Results PR Newswire
Apr-26-17 08:00AM  New Kristalose® Growth Driver Established Through Co-Promotion Agreement PR Newswire
Mar-31-17 05:23PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Mar-27-17 04:15PM  Caldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use PR Newswire
Mar-22-17 05:28PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Stateme
02:34PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc. Accesswire
Mar-21-17 09:26AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube
09:26AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
Mar-17-17 09:37AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc. Business Wire
Mar-16-17 05:05PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
01:04PM  CUMBERLAND PHARMACEUTICALS INC Financials
Mar-15-17 01:13PM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Capital Cube
01:13PM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-13-17 06:06AM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
Mar-10-17 05:07PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
Mar-07-17 08:18PM  Edited Transcript of CPIX earnings conference call or presentation 7-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
06:26PM  Cumberland reports 4Q loss Associated Press
04:15PM  Cumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results PR Newswire
07:07AM  Q4 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
Feb-28-17 04:15PM  Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results PR Newswire
Feb-10-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Feb-07-17 08:15AM  Caldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics PR Newswire
Feb-03-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jan-30-17 08:15AM  U.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case PR Newswire
Jan-20-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Jan-16-17 08:15AM  Cumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors PR Newswire
Jan-13-17 05:02PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jan-09-17 09:30AM  Cumberland Pharmaceuticals and Clinigen Enter Exclusive U.S. Commercialization Agreement For Totect® PR Newswire
Dec-21-16 12:13PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : December 21, 2016
Nov-21-16 05:17PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Nov-17-16 08:15AM  Blog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market Accesswire
Nov-16-16 08:00AM  Cumberland Pharmaceuticals Acquires U.S. Rights to Nordic Group's Methotrexate Injection Products PR Newswire +6.80%
Nov-07-16 08:30AM  Cumberland Pharmaceuticals Presentation Now Available for On-Demand Viewing PR Newswire
Nov-04-16 12:34PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : November 4, 2016
Nov-03-16 05:15PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
10:59AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q3, 2016 By the Numbers : November 3, 2016
Nov-02-16 12:45PM  Edited Transcript of CPIX earnings conference call or presentation 1-Nov-16 8:30pm GMT +5.39%
Nov-01-16 06:05PM  Cumberland posts 3Q profit
04:05PM  Cumberland Pharmaceuticals Reports Third Quarter & Year To Date 2016 Financial Results PR Newswire
07:07AM  Q3 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
Oct-31-16 11:10AM  Public Company Executives to Present Online to Investors on November 3 PR Newswire
Oct-28-16 08:30AM  Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com November 3 PR Newswire
Oct-25-16 04:05PM  Cumberland Pharmaceuticals To Announce Third Quarter 2016 Financial Results PR Newswire
Oct-18-16 10:03AM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : October 18, 2016
Sep-30-16 05:23PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Sep-26-16 08:30AM  Cumberland Pharmaceuticals Launches Promotion Of Ethyol® In The United States For Oncology Patient Support PR Newswire -6.22%
Sep-16-16 05:07PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Sep-14-16 04:05PM  Cumberland Pharmaceuticals Announces New Program To Develop Portaban For Portal Hypertension PR Newswire
Sep-08-16 10:12AM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : September 8, 2016
Aug-26-16 05:01PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Aug-23-16 04:05PM  Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol® (amifostine) For Oncology Patient Support PR Newswire
Aug-11-16 12:40PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : August 11, 2016
Aug-09-16 12:14PM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Aug-05-16 05:09PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
05:07PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
Aug-02-16 06:49PM  Cumberland posts 2Q loss
06:39PM  Edited Transcript of CPIX earnings conference call or presentation 2-Aug-16 8:30pm GMT
04:05PM  Cumberland Pharmaceuticals Reports Second Quarter 2016 Financial Results PR Newswire
07:07AM  Q2 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
Jul-26-16 04:05PM  Cumberland Pharmaceuticals To Announce Second Quarter 2016 Financial Results PR Newswire
Jul-20-16 12:17PM  ETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 20, 2016
Jul-18-16 09:00AM  Cumberland Pharmaceuticals To Participate In Avondale Partners' 4th Annual Healthcare Conference PR Newswire
Jun-10-16 05:20PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
08:00AM  Cumberland Pharmaceuticals Announces Caroline Young To Join Its Board Of Directors PR Newswire
May-17-16 02:21PM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2016 By the Numbers
May-13-16 04:59PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
May-10-16 06:33PM  Edited Transcript of CPIX earnings conference call or presentation 10-May-16 8:30pm GMT
05:59PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
05:36PM  Cumberland reports 1Q loss
04:05PM  Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results PR Newswire
07:07AM  Q1 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
07:00AM  Cumberland Pharmaceuticals and Clinigen Group enter into exclusive U.S. commercialization agreement for oncology support drug Ethyol® PR Newswire
May-03-16 04:15PM  Cumberland Pharmaceuticals To Announce First Quarter 2016 Financial Results PR Newswire
Apr-29-16 06:53PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
03:30PM  How this Nashville health care company stocked its pipeline with the help of big pharma at American City Business Journals
Apr-27-16 08:00AM  Cumberland Pharmaceuticals Announces New Program To Develop Vasculan For Systemic Sclerosis PR Newswire
Apr-08-16 10:15AM  Cumberland Pharmaceuticals Inc (CPIX): Ariel Investments Snapping Up Shares at Insider Monkey
Mar-24-16 07:46AM  Caldolor® Launched For The Treatment Of Pain And Fever In Children at noodls
07:30AM  Caldolor® Launched For The Treatment Of Pain And Fever In Children PR Newswire
Mar-14-16 05:31PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
Mar-09-16 05:21PM  CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
11:39AM  Cumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: 2015 By the Numbers
Mar-03-16 05:34PM  Cumberland posts 4Q profit
07:07AM  Q4 2015 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
Feb-25-16 04:05PM  Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2015 Financial Results PR Newswire +5.26%
Feb-10-16 08:30AM  Vaprisol Dose Comparison Published Supporting Its Efficacy, Safety And Pharmacokinetics PR Newswire
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for hospital acute care and gastroenterology markets in the United States and internationally. It marketed products include Acetadote (acetylcysteine) injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative; Vaprisol (conivaptan) injection for treating hyponatremia; Omeclamox-Pak for the treatment of H. pylori infection and duodenal ulcer disease; and Ethyol (amifostine) for injection to treat oncology patients. The company's product candidates in Phase II clinical trials comprise Hepatoren (ifetroban) injection for the treatment of hepatorenal syndrome; Boxaban (ifetroban) oral capsule for the treatment of aspirin-exacerbated respiratory disease; Vasculan (ifetroban) oral capsule for the treatment of systemic sclerosis; and Portaban for the treatment of portal hypertension. Its pre-approval products consist of Methotrexate injection for treating active rheumatoid, juvenile idiopathic, and psoriatic arthritis, as well as disabling psoriasis; and Totect injection for emergency oncology intervention, which helps to reverse the toxic effects of anthracycline chemotherapy in case of extravasation. The company markets and sells its products through sales representatives and district managers. Cumberland Pharmaceuticals Inc. has a strategic alliance with Clinigen Group plc, Nordic Group B.V., and Cumberland Emerging Technologies. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bonner MichaelChief Financial OfficerAug 23Buy6.725003,36015,447Aug 25 04:57 PM
Bonner MichaelChief Financial OfficerMay 31Buy6.953002,08514,947Jun 02 05:21 PM
Griggs JonathanDirectorMay 31Sale6.978,00055,76010,803Jun 02 05:22 PM
Lawrence Thomas RDirectorApr 07Sale6.406,00038,4000Apr 07 05:01 PM
Bonner MichaelChief Financial OfficerMar 23Buy6.429005,77812,800Mar 24 05:00 PM
Krogulski KennethDirectorMar 21Buy6.5315,00097,950150,000Mar 24 04:59 PM
Lawrence Thomas RDirectorMar 13Sale6.2420,781129,6736,000Mar 15 05:00 PM
Bonner MichaelChief Financial OfficerNov 17Buy5.509004,95011,900Nov 18 05:13 PM
Lawrence Thomas RDirectorNov 15Sale5.0718,60094,30226,781Nov 18 05:14 PM